Girón-González José A, Martínez-Sierra Carmen, Rodriguez-Ramos Claudio, Macías Manuel A, Rendón Paloma, Díaz Fernando, Fernández-Gutiérrez Clotilde, Martín-Herrera Leopoldo
Internal Medicine, Hospital Universitario Puerta del Mar, 11009 Cadiz, Spain.
Liver Int. 2004 Oct;24(5):437-45. doi: 10.1111/j.1478-3231.2004.0951.x.
BACKGROUND/AIMS: Increased serum concentrations of pro-inflammatory cytokines have been detected in patients with liver cirrhosis. However, their role in the natural history of cirrhosis and portal hypertension, in the absence of infection, and the prognostic significance of inflammation-related cytokines have not been reported. Our objective was the analysis of the prognostic value of inflammation-related cytokines in cirrhotic patients.
Serum concentrations of tumor necrosis factor (TNF-alpha) and its soluble receptors I and II and interleukin 6 (IL-6), as well as mean blood pressure, plasma renin activity, aldosterone, vasopressin and norepinephrine concentrations were determined in 72 cirrhotic patients (Child-Pugh score: A 50%, B 33.3%, C 16.7%), without any evidence of infection, and in 25 healthy controls. Patients were followed up for a median of 35.9 (range 6-60) months.
Increased concentrations of soluble TNF receptors were detected in cirrhotic patients when compared with healthy controls. TNF receptors and IL-6 concentrations were both significantly more elevated in advanced phases of cirrhosis (Child-Pugh score C vs B and vs A). Sixteen patients died as a related consequence of liver cirrhosis. Multivariant analysis demonstrated that Child-Pugh score, mean blood pressure and serum levels of TNF receptor I were associated with mortality.
In addition to the classic factors implicated in mortality (Child-Pugh score and hemodynamic parameters), alterations in inflammation-related components are of prognostic significance in cirrhotic patients.
背景/目的:肝硬化患者血清促炎细胞因子浓度升高。然而,在无感染情况下,它们在肝硬化自然病程和门静脉高压中的作用以及炎症相关细胞因子的预后意义尚未见报道。我们的目的是分析炎症相关细胞因子在肝硬化患者中的预后价值。
测定了72例无任何感染迹象的肝硬化患者(Child-Pugh评分:A 级占50%,B级占33.3%,C级占16.7%)以及25例健康对照者的血清肿瘤坏死因子(TNF-α)及其可溶性受体I和II、白细胞介素6(IL-6)的浓度,同时测定了平均血压、血浆肾素活性、醛固酮、血管加压素和去甲肾上腺素浓度。对患者进行了中位时间为35.9(范围6 - 60)个月的随访。
与健康对照相比,肝硬化患者可溶性TNF受体浓度升高。TNF受体和IL-6浓度在肝硬化晚期(Child-Pugh评分C级与B级和A级相比)均显著升高。16例患者死于肝硬化相关并发症。多变量分析表明,Child-Pugh评分、平均血压和TNF受体I血清水平与死亡率相关。
除了与死亡率相关的经典因素(Child-Pugh评分和血流动力学参数)外,炎症相关成分的改变在肝硬化患者中具有预后意义。